• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于德国不同社会人口群体的迷幻剂使用不同剂量类型的人群估计。

Population-based estimates of different dosage types of psychedelic use across socio-demographic groups in Germany.

作者信息

Sattler Sebastian, Wood Suzanne, Petersen Margit Anne, Seiffert Fiona, Mehlkop Guido

机构信息

Faculty of Sociology, Bielefeld University, 33615, Bielefeld, Germany.

Center for Uncertainty Studies (CeUS), Bielefeld University, 33615, Bielefeld, Germany.

出版信息

Sci Rep. 2025 May 29;15(1):18952. doi: 10.1038/s41598-025-03873-0.

DOI:10.1038/s41598-025-03873-0
PMID:40442205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12122786/
Abstract

Psychedelic drugs, particularly taking small amounts of psychedelics in a cyclical pattern over days (so-called microdosing), have garnered growing scientific and public interest, but representative data on different dosage levels is scarce. To better understand this trend, we surveyed a nationwide sample of 11,299 adults in Germany. The survey assessed lifetime and past six-month psychedelic use by dosage as well as socio-demographic variables (sex, age, education, employment status, household equivalence income, partner arrangements, and place of residence). Results show that 5.0% of respondents self-reported lifetime psychedelic use, while 0.7% reported past six-month use. Medium to high dosing was more prevalent than microdosing. Moreover, high probabilities of using multiple forms of psychedelics were uncovered. We also observed variation in use across socio-demographic groups. For example, psychedelics use was less likely in females than males, and older than younger respondents. Past six-month microdosing was less likely in rural areas, and past six-month medium to high dosing was less prevalent in individuals with higher income or who live with a partner. This study shows limited support for widespread use in Germany and highlights diverse usage patterns across socio-demographics. These findings can inform policies, especially considering the overlap in usage of various substances.

摘要

迷幻药物,特别是在数天内以周期性模式服用少量迷幻药物(即所谓的微剂量服用),已引起越来越多的科学关注和公众兴趣,但关于不同剂量水平的代表性数据却很匮乏。为了更好地理解这一趋势,我们对德国全国范围内的11299名成年人进行了抽样调查。该调查评估了按剂量划分的终生及过去六个月内的迷幻药物使用情况,以及社会人口统计学变量(性别、年龄、教育程度、就业状况、家庭等效收入、伴侣安排和居住地点)。结果显示,5.0%的受访者自我报告有终生迷幻药物使用经历,而0.7%的受访者报告在过去六个月内使用过。中等至高剂量使用比微剂量使用更为普遍。此外,还发现了使用多种迷幻药物形式的高概率情况。我们还观察到不同社会人口群体在使用情况上的差异。例如,女性使用迷幻药物的可能性低于男性,年龄较大者低于年龄较小者。农村地区过去六个月内微剂量使用的可能性较小,而收入较高或有伴侣共同生活的个人过去六个月内中等至高剂量使用的情况则不太普遍。这项研究表明德国广泛使用迷幻药物的情况得到的支持有限,并突出了不同社会人口群体的多样化使用模式。这些发现可为政策提供参考,尤其是考虑到各种物质使用情况的重叠。

相似文献

1
Population-based estimates of different dosage types of psychedelic use across socio-demographic groups in Germany.基于德国不同社会人口群体的迷幻剂使用不同剂量类型的人群估计。
Sci Rep. 2025 May 29;15(1):18952. doi: 10.1038/s41598-025-03873-0.
2
The Global Psychedelic Survey: Consumer characteristics, patterns of use, and access in primarily anglophone regions around the world.全球迷幻药物调查:主要以英语为母语的国家和地区的消费者特征、使用模式和获取途径。
Int J Drug Policy. 2024 Aug;130:104507. doi: 10.1016/j.drugpo.2024.104507. Epub 2024 Jun 26.
3
Self-blinding citizen science to explore psychedelic microdosing.自我蒙蔽的公民科学探索迷幻微剂量。
Elife. 2021 Mar 2;10:e62878. doi: 10.7554/eLife.62878.
4
Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders.迷幻药微剂量自我管理治疗精神和物质使用障碍的感知结果。
Psychopharmacology (Berl). 2020 May;237(5):1521-1532. doi: 10.1007/s00213-020-05477-0. Epub 2020 Feb 11.
5
Prevalence and epidemiological associates of novel psychedelic use in the United States adult population.美国成年人群中新致幻剂使用的流行率和流行病学关联。
J Psychopharmacol. 2019 Sep;33(9):1058-1067. doi: 10.1177/0269881119827796. Epub 2019 Feb 28.
6
Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities.微剂量使用迷幻药:人口统计学、使用方法和精神共病。
J Psychopharmacol. 2020 Jun;34(6):612-622. doi: 10.1177/0269881120908004. Epub 2020 Feb 28.
7
Microdosing psychedelics: Motivations, subjective effects and harm reduction.微剂量使用迷幻剂:动机、主观效应和减少危害。
Int J Drug Policy. 2020 Jan;75:102600. doi: 10.1016/j.drugpo.2019.11.008. Epub 2019 Nov 25.
8
State Cannabis and Psychedelic Legislation and Microdosing Interest in the US.美国的大麻和迷幻药立法及微量用药兴趣状况。
JAMA Health Forum. 2024 Jun 7;5(6):e241653. doi: 10.1001/jamahealthforum.2024.1653.
9
Co-use of psychedelics with other substances: Findings from the global psychedelic survey.迷幻剂与其他物质的共同使用:全球迷幻剂调查结果
J Psychopharmacol. 2025 May;39(5):453-462. doi: 10.1177/02698811241292956. Epub 2024 Oct 28.
10
Psychedelic Microdosing: Prevalence and Subjective Effects.迷幻微剂量:流行程度和主观效应。
J Psychoactive Drugs. 2020 Apr-Jun;52(2):113-122. doi: 10.1080/02791072.2020.1718250. Epub 2020 Jan 23.

本文引用的文献

1
Global Trends in Psychedelic Microdosing: Demographics, Substance Testing Behavior, and Patterns of Use.
J Psychoactive Drugs. 2024 Nov 6:1-11. doi: 10.1080/02791072.2024.2424284.
2
Co-use of psychedelics with other substances: Findings from the global psychedelic survey.迷幻剂与其他物质的共同使用:全球迷幻剂调查结果
J Psychopharmacol. 2025 May;39(5):453-462. doi: 10.1177/02698811241292956. Epub 2024 Oct 28.
3
Psychedelic public health: State of the field and implications for equity.迷幻公共卫生:领域现状及其对公平性的影响。
Soc Sci Med. 2024 Sep;357:117134. doi: 10.1016/j.socscimed.2024.117134. Epub 2024 Jul 14.
4
State Cannabis and Psychedelic Legislation and Microdosing Interest in the US.美国的大麻和迷幻药立法及微量用药兴趣状况。
JAMA Health Forum. 2024 Jun 7;5(6):e241653. doi: 10.1001/jamahealthforum.2024.1653.
5
Germany's cannabis act: a catalyst for European drug policy reform?德国的大麻法案:欧洲毒品政策改革的催化剂?
Lancet Reg Health Eur. 2024 May 14;42:100929. doi: 10.1016/j.lanepe.2024.100929. eCollection 2024 Jul.
6
Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review.迷幻心理治疗的安全性与风险评估:一项荟萃分析与系统评价
Psychiatry Res. 2024 May;335:115880. doi: 10.1016/j.psychres.2024.115880. Epub 2024 Mar 31.
7
Race, Ethnic, and Sex Differences in Prevalence of and Trends in Hallucinogen Consumption Among Lifetime Users in the United States Between 2015 and 2019.2015年至2019年间美国终生致幻剂使用者中致幻剂消费流行率及趋势的种族、民族和性别差异。
Front Epidemiol. 2022 Mar 23;2:876706. doi: 10.3389/fepid.2022.876706. eCollection 2022.
8
Use of Lysergic Acid Diethylamide by Major Depression Status.使用麦角酸二乙酰胺治疗重度抑郁症。
JAMA Psychiatry. 2024 Jan 1;81(1):89-96. doi: 10.1001/jamapsychiatry.2023.3867.
9
Case analysis of long-term negative psychological responses to psychedelics.对迷幻剂的长期负面心理反应的案例分析。
Sci Rep. 2023 Sep 25;13(1):15998. doi: 10.1038/s41598-023-41145-x.
10
Typology of Users of Psychedelics and Alike Psychoactive Substances in Czechia: Results of the National Online Survey.捷克使用迷幻剂和类似精神活性物质的用户类型学:全国在线调查结果。
J Psychoactive Drugs. 2023 Nov-Dec;55(5):601-611. doi: 10.1080/02791072.2023.2177908. Epub 2023 Feb 24.